Stamos Capital Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.33M | Buy |
40,164
+12,978
| +48% | +$1.08M | 0.6% | 56 |
|
|
2025
Q1 | $2.2M | Sell |
27,186
-11,504
| -30% | -$933K | 0.58% | 56 |
|
|
2024
Q4 | $3.48M | Buy |
38,690
+13,230
| +52% | +$1.19M | 0.82% | 36 |
|
|
2024
Q3 | $2.52M | Buy |
25,460
+4,270
| +20% | +$422K | 0.59% | 53 |
|
|
2024
Q2 | $1.96M | Buy |
21,190
+8,120
| +62% | +$753K | 0.42% | 66 |
|
|
2024
Q1 | $1.24M | Buy |
+13,070
| New | +$1.24M | 0.28% | 82 |
|
|
2023
Q1 | – | Sell |
-12,090
| Closed | -$1M | – | 132 |
|
|
2022
Q4 | $1M | Sell |
12,090
-1,170
| -9% | -$97.1K | 0.32% | 70 |
|
|
2022
Q3 | $1.05M | Buy |
+13,260
| New | +$1.05M | 0.27% | 76 |
|
|
2020
Q2 | – | Sell |
-26,264
| Closed | -$2.03M | – | 84 |
|
|
2020
Q1 | $2.03M | Buy |
26,264
+21,004
| +399% | +$1.63M | 1.07% | 36 |
|
|
2019
Q4 | $500K | Buy |
+5,260
| New | +$500K | 0.4% | 42 |
|
|
2019
Q3 | – | Sell |
-11,500
| Closed | -$1.02M | – | 54 |
|
|
2019
Q2 | $1.02M | Sell |
11,500
-18,000
| -61% | -$1.59M | 1.02% | 22 |
|
|
2019
Q1 | $2.71M | Sell |
29,500
-15,500
| -34% | -$1.42M | 3.47% | 4 |
|
|
2018
Q4 | $3.23M | Buy |
+45,000
| New | +$3.23M | 2.43% | 9 |
|